NGVT — Ingevity Corp
—
NYSE ·
Materials ·
Chemicals ·
CIK 1653477 ·
Last close
$59.28
Market Cap
$2.00B
52W High
$79.29
52W Low
$46.38
ADV30
359,449
Next earnings
2026-11-04
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 314,100,000 | 139,000,000 | 93,900,000 | 35,300,000 | 1,537,500,000 | 97,400,000 | 1,490,600,000 |
| Mar 2026 | 258,000,000 | 116,400,000 | 69,000,000 | 59,800,000 | 1,650,200,000 | 95,400,000 | 1,611,300,000 |
| Dec 2025 | 255,100,000 | 87,800,000 | 38,800,000 | -84,600,000 | 1,651,100,000 | 78,100,000 | 1,621,400,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$211,000,000
Investing CF
$138,500,000
Financing CF
$-277,600,000
CapEx
$-56,100,000
Dividends Paid
—
Buybacks
$-143,100,000
EPS Diluted TTM
$1.70
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$500,000,000
Inventory
$154,000,000
Receivables
$155,800,000
ST Investments
—
EBIT TTM
$106,300,000
Pretax Income TTM
$37,700,000
Interest Exp TTM
$68,600,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,132,300,032
EBITDA
$371,500,000
Free Cash Flow
$70,325,000
Enterprise Value
$3,122,215,936
Total Cash
$85,400,000
Total Debt
$1,145,500,032
Shares Out
33,780,725
Trailing EPS
$1.05
Book Value
$1.84
ROE
35.3%
ROA
10.8%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,167,600,000 | 261,900,000 | -167,100,000 | 1,651,100,000 | 1,621,400,000 | 29,700,000 | 331,200,000 |
| Dec 2024 | 1,200,100,000 | 282,500,000 | -430,300,000 | 2,022,600,000 | 1,827,400,000 | 195,200,000 | 128,600,000 |
| Dec 2023 | 1,215,500,000 | 257,800,000 | -5,400,000 | 2,623,300,000 | 1,991,900,000 | 631,400,000 | 205,100,000 |
| Dec 2022 | 1,668,300,000 | 341,000,000 | 211,600,000 | 2,736,500,000 | 2,038,200,000 | 698,300,000 | 313,400,000 |
TTM Snapshot
Revenues TTM
$1,090,600,000
NetIncome TTM
$54,000,000
OpCashFlow TTM
—
Assets (Latest)
$1,537,500,000
Forward EPS
$6.01
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $60.00 · spot: $58.31 · call volume: 35 · put volume: 2Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IOSP | INNOSPEC INC. | $1.92B | $78.01 | — |
| OLN | OLIN Corp | $1.91B | $16.72 | — |
| MTX | MINERALS TECHNOLOGIES INC | $1.86B | $59.77 | — |
| CURLF | Curaleaf Holdings, Inc. | $1.86B | $7.95 | — |
| ROG | ROGERS CORP | $2.19B | $122.81 | — |
News headlines (Yahoo Finance, 1h cache)
Ingevity (NGVT) Lifted EPS Guidance, Is The Stock Still Cheap?
2026-11-09 23:23 · Yahoo
Ingevity Q3 Earnings Call Highlights
2026-11-08 08:14 · Yahoo
Ingevity (NGVT) Q3 2026 Earnings Call Transcript
2026-11-05 22:22 · Yahoo
Ingevity (NGVT) Surpasses Q3 Earnings and Revenue Estimates
2026-11-04 23:45 · Yahoo
Ingevity: Q3 Earnings Snapshot
2026-11-04 22:03 · Yahoo
Ingevity reports third quarter 2026 financial results
2026-11-04 21:15 · Yahoo
Ingevity Celebrates 10 Years as a Public Company with NYSE Closing Bell® Ringing
2026-10-27 12:00 · Yahoo
Is NGVT Positioned for Further Adjusted EBITDA Improvement?
2026-10-15 13:34 · Yahoo
Here's Why You Should Hold Onto Ingevity Stock for Now
2026-10-07 13:00 · Yahoo
Ingevity announces dates for third quarter 2026 earnings release and webcast
2026-10-07 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.